Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp
- Conditions
- Cancer Head NeckSquamous Cell CarcinomaSurgery
- Registration Number
- NCT05987579
- Lead Sponsor
- Maastricht University Medical Center
- Brief Summary
This study examines tumor- en surgical characteristics of stage T3 cutaneous squamous cell carcinomas on the scalp, diagnosed between 2010 and 2018. Histological data and patient- and tumor characteristics were collected.
- Detailed Description
Cutaneous squamous cell carcinoma is the second most common type of non-melanoma skin cancer, following basal cell carcinoma. Following the American Joint Committee on Cancer Tumour, Node and Metastasis (TNM) Classification of Malignant Tumors staging system (TNM8), T3 cutaneous squamous cell carcinomas comprise an interesting group, especially on the scalp, because of the thin subcutaneous fat layer. According to the TNM8 criteria, T3 include all cutaneous squamous cel carcinomas with greatest tumor dimension ≥4cm, tumors with minimal bone erosion or perineural growth (defined as involvement of the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1mm or larger in caliber or showing clinical or radiographic involvement of nerves without invasion of the skull base) or with deep invasion. Deep invasion is defined as invasion deeper than the subcutaneous fat or a tumor thickness \>6mm. The scalp has a natural anatomical and oncological barrier for extension in depth known as the epicranial aponeurosis, also called the galea aponeurotica.
This retrospective study, examines the tumor- en surgical characteristics of these stage T3 cutaneous squamous cell carcinomas on the scalp.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 104
- stage T3 cutaneous squamous cell carcinoma of the scalp (histologically proven)
- surgical treatment or radiotherapy treatment
- metastasis by diagnosis
- stage T1/T2/T4
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients characteristics Between 2010-2017 Risk factors, comorbidities
Tumor characteristics Between 2010-2017 Histological data on invasion depth, tumor differentiation
Surgical characteristics Between 2010-2017 Choice of treatment, complications, reconstruction types
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ellen Oyen
🇳🇱Maastricht, Netherlands